Trial intelligence / Profile preview

Voclosporin vs placebo in active lupus nephritis (phase 3, Japan)

jRCT2080223765Phase 3Completed

Sponsor
Aurinia
Start
Jan 2018
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial in lupus nephritis (LN) comparing Voclosporin arm with Placebo arm (2 arms). Primary endpoint: Renal response rate. Started Jan 2018; status: completed.

02

Drugs

voclosporin
03

Conditions

lupus nephritis (LN)

Beyond the preview

Go deeper on jRCT2080223765.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080223765.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call